Phocas Financial Corp. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 156 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
Phocas Financial Corp. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$1,429,000
-34.4%
135,816
-3.6%
0.19%
-43.5%
Q4 2020$2,180,000
-11.9%
140,867
-16.9%
0.33%
-21.6%
Q3 2020$2,475,000169,5250.42%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders